Aligned Genetics, Inc. (KOSDAQ:238120)

Aligned Genetics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 19, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	54,406	43,496	57,947	54,137	61,614	71,176
Market Cap Growth	22.65%	-24.94%	7.04%	-12.13%	-13.43%	46.13%
Enterprise Value	41,561	31,551	48,198	44,338	52,552	59,031
Last Close Price	3870.00	3025.00	4030.00	3765.00	4285.00	4950.00
PE Ratio	14.68	10.54	17.91	23.21	11.12	152.01
PS Ratio	3.14	2.76	3.81	3.94	5.24	8.95
PB Ratio	1.53	1.23	1.85	1.88	2.28	3.32
P/TBV Ratio	1.54	1.23	1.85	1.88	2.29	3.34
P/FCF Ratio	410.26	15.49	29.41	244.98	-	-
P/OCF Ratio	91.56	14.19	20.34	24.36	453.15	1995.34
EV/Sales Ratio	2.40	2.00	3.17	3.22	4.47	7.42
EV/EBITDA Ratio	11.92	9.40	12.15	12.67	19.34	139.69
EV/EBIT Ratio	14.20	11.35	14.44	15.56	24.12	-
EV/FCF Ratio	313.40	11.24	24.47	200.64	-	-
Debt / Equity Ratio	0.08	0.08	0.15	0.15	0.16	0.05
Debt / EBITDA Ratio	0.81	0.88	1.18	1.25	1.63	2.67
Debt / FCF Ratio	21.17	1.06	2.37	19.82	-	-
Net Debt / Equity Ratio	-0.36	-0.41	-0.33	-0.32	-0.32	-0.51
Net Debt / EBITDA Ratio	-3.72	-4.37	-2.59	-2.66	-3.20	-26.05
Net Debt / FCF Ratio	-96.86	-5.23	-5.21	-42.16	2.74	181.20
Asset Turnover	0.40	0.37	0.39	0.39	0.39	0.32
Inventory Turnover	1.11	1.15	1.20	1.64	1.98	1.62
Quick Ratio	7.14	10.86	3.37	11.38	10.98	11.18
Current Ratio	10.05	13.49	4.12	14.67	12.97	13.07
Return on Equity (ROE)	10.93%	12.36%	10.76%	8.36%	22.87%	2.21%
Return on Assets (ROA)	4.20%	4.08%	5.36%	4.99%	4.54%	-0.63%
Return on Invested Capital (ROIC)	13.20%	12.07%	15.54%	14.39%	15.16%	-2.70%
Return on Capital Employed (ROCE)	6.80%	6.60%	9.30%	8.00%	6.60%	-1.00%
Earnings Yield	6.88%	9.49%	5.58%	4.31%	8.99%	0.66%
FCF Yield	0.24%	6.46%	3.40%	0.41%	-5.15%	-0.08%
Buyback Yield / Dilution	1.33%	-	-	-	-38.26%	27.67%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.